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Background: Public reporting of institution- and individual-level performance data has recently become a popular
topic in the health care field. This study (1) evaluated the perceptions of general practitioners on the public
reporting of institutional and individual medicine prescribing data in primary care institutions, and (2) compared the
difference among the perceptions of general practitioners on the dimensions of necessity, methodological rigor,
and impact of public reporting medicine prescribing data.
Methods: We conducted a survey in 10 primary care institutions in Q city, Hubei province. General practitioners
who hold prescribing license were eligible for this study; we surveyed all eligible general practitioners in July 2014.
The survey instrument was developed based on previous studies and expert opinions. Paired t-test or
nonparametric test was used to evaluate the difference in perceptions between the institutional and individual
medicine prescribing data reporting. An analysis of variance test was used to analyze the score differences among
the three dimensions (i.e., necessity, methodological rigor, and impact).
Results: A total of 154 general practitioners were surveyed in this study. No significant difference in the perceptions of
general practitioners was observed between the institution- and individual-level medicine prescribing data reporting
(p > 0.05). General practitioners have significantly different perceptions on the three dimensions of the institution- and
individual-level data reporting (p < 0.05). Methodological rigor obtained the lowest score. Regarding the strategies to
facilitate the medicine prescribing data reporting, over 80 % of general practitioners selected the items that disclose
process measures and not outcome measures, as well as educate patients on data interpretation.
Conclusion: The perceptions of general practitioners between institution- and individual-level data reporting have no
significant difference. General practitioners place their utmost concern on public reporting on the methodological
rigor. Processing measures and patient education to improve the efficiency of public reporting require substantial
attention.
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In recent decades, public reporting has been used as a
vehicle to improve the performance at the institutional and
individual levels [1]. Hospital-level public reporting is cur-
rently familiar to most clinicians, whereas physician-level
reporting is rapidly progressing and becoming increasingly
prevalent [2]. In the US, the outcomes data for individual* Correspondence: xpzhang602@163.com
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of New York, Pennsylvania, and New Jersey since 1991,
1992, and 1994, respectively [3]. Thereafter, an independ-
ent newsroom in the US published the nationwide compli-
cation rates of nearly 17,000 surgeons in 2005 [1]. In 2005,
the Society for Cardiothoracic Surgery (SCTS) in Great
Britain and Ireland published publicly accessible perform-
ance data of individual hospitals and surgeons [4]. In 2013,
England became the first country to mandate the release of
the names of surgeons and outcome data associated with
surgeons across nine surgical specialties [1].le is distributed under the terms of the Creative Commons Attribution 4.0
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fers several potential benefits. First, public reporting enables
patients to identify the best physicians and hospitals, as well
as to make informed choices [5]. Second, public reporting
will increase competition within the health care system and
offer physicians and hospitals incentives to improve quality
[2, 6]. Third, public reporting provides policymakers and
third-party payers with knowledge for informed decisions
on payment, including rewarding high or penalizing low
performers [7, 8]. Public reporting does, however, have
several unintended consequences. For example, providers
may become risk averse, clinical priorities may become
distorted, and staff morale may be reduced [9]. In addition,
the inadequate risk adjustment, lack of valid quality metrics
and validated data are cited by critics [6].
Although public reporting is being extensively studied,
the perceptions of physicians on the public reporting of
hospital- and physician-level performance data are limited.
Ross et al. conducted qualitative interviews to explore the
perceptions of physicians on public reporting, and indi-
cated that the interviewees expressed skepticism regarding
public reporting because of concerns on the ability of
patients to comprehend the performance data. However,
Ross et al. were only focused on the perceptions of physi-
cians on the hospital level performance data reporting
[10]. Sherman et al. evaluated the perceptions of surgeons
on the public reporting of the hospital- and individual-
level surgical qualities. The investigated surgeons
expressed concerns regarding public reporting, particu-
larly the reporting of individual performance, and were
more in favor of public reporting of hospital level out-
comes data [6]. Nevertheless, Sherman’s study focused on
the perceptions of surgeons, and perceptions may not be
generalizable to other medical workers, such as the gen-
eral practitioners (GPs) in primary care institutions. GPs
play a gatekeeping role in the health care system [11].
Therefore, gaining an improved understanding of the
perceptions of GPs on the public reporting of the hospital-
and individual-level performance data may facilitate the
acceptance of public reporting, improve performance, and
enrich the evidence of public reporting research.
This study intends to answer the following questions:
(1) Do GPs have different perceptions on the public
reporting of the institution- and individual-level medi-
cine prescribing data in primary care institutions? (2)
What is the difference among the perceptions of GPs on
the necessity, methodological rigor, and impact of medi-
cine prescribing data reporting?
Methods
Setting and participants
This study was conducted in Q city, Hubei Province,
and involved 10 primary care institutions. Q city is
located in central Hubei, with a land area of 2004 km2and a population of 0.95 million. The annual GDP of Q
city reached 49.3 billion (RMB yuan) in 2013, just above
the average level of all cities in Hubei. The majority of
inhabitants in Q city are of Han ethnicity, with about
8000 from Hui, Tujia, and other ethnic groups. The
population serviced by the 10 primary care institutions
was about 383, 000; outpatient visits was about 49,108;
and inpatient was about 1, 482 per year. The majority of
patients (about 60 %) of the 10 primary care institutions
were covered by New Cooperative Medical Scheme
(NCMS); about 20 % patients were covered by other med-
ical insurances (basic medical insurance for urban em-
ployees, basic medical insurance for urban residents); and
the rest 20 % patients paid at their own expense. For the
NCMS, the reimbursement rate is about 85 % for inpa-
tients and about 50 % for outpatient in the Q city.
We selected Q city because the institutional and indi-
vidual medicine prescribing data have been released to
public in November 2013 to promote the rational use of
medicine. The public reporting had already last for
9 months when we conducted the investigation. Besides,
the health authority of Q city was very supportive of this
project and it guaranteed the investigation conducted
smoothly. Three prescribing indicators using the out-
patient prescription data were calculated at the institu-
tion- and individual-levels: percentage of prescriptions
requiring antibiotics; percentage of prescriptions requir-
ing injections; and average drug expenditure per pre-
scription. These indicators were ranked in order at the
institutional level within 10 institutions and the individ-
ual prescriber level within an institution on a monthly
basis. The ranking results were displayed in a public
place (entrance hall).
GPs with prescribing license from the 10 primary care
institutions were eligible for this study. We calculated




where, Z1 − α/2 is the value obtained from the standard
normal distribution table for 100 (1-α)% confidence
level. Its value for 95 % and 99 % confidence level is 1.96
and 2.58 respectively, P is the anticipated proportion of
the condition in the study population and ε is the rela-
tive precision [12].
According previous study, about 79 % of the doctors
are aware of public reporting [13]. The minimum sample
size required for this study for relative precision of 10 %
and confidence level of 95 % was 103.
All of the 154 eligible GPs of the 10 primary care insti-
tutions would be surveyed on considering of response
rate. The investigation was conducted in July 2014.
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Tongji Medical College, Huazhong University of Science
and Technology (NO: IORG 0003571). An introductory
letter was attached to the questionnaire to explain the
objectives of this study, and verbally informed consent
was obtained from the survey participants. Permission
was also granted by the local health authority.
Instrument
The items were developed based on Sherman’s survey
instrument and expert opinions; these items were
modified for applicability to the research site and tar-
get population [6].
The structured instrument included 3 dimensions and
33 items (i.e., 16 pairs of questions on the perceptions of
institution- and individual-level data reporting, as well
as a question on the strategies on facilitating public
reporting). Five-point Likert scale response options were
used in the instrument; the higher the score, the more
positive response to public reporting.
The first dimension was perceptions on the necessity of
public reporting, including whether public reporting is ne-
cessary, and whether third-party reporting is necessary (1 =
not at all necessary, 2 = slightly necessary, 3 = somewhat
necessary, 4 = very necessary, 5 = extremely necessary).
The second dimension covered the perceptions on the
methodological rigor of public reporting, that is, whether
GPs are concerned with the following issues: patients cannot
interpret or recognize data complexity, the public reporting
data are unreliable, a lack of appropriate medicine prescrib-
ing metrics, have no adequate risk adjustment, have no
adequate amount of prescriptions for statistical comparison,
a lake of transparency of methodology (1 = extremely con-
cerned, 2 =moderately concerned, 3 = somewhat concerned,
4 = slightly concerned, 5 = not at all concerned).
The third dimension was perceptions on the impact of
public reporting, covering positive impact perceptions and
negative impact perceptions. The positive impact percep-
tions of public reporting include: improving prescription
quality, learning more knowledge on rational prescription
of medicines, and providing a sense of achievement to
GPs (1 = strongly disagree, 2 = disagree, 3 = neither agree
nor disagree, 4 = agree, 5 = strongly agree). The negative
impact perceptions of public reporting include: causing
risk averse, damaging quality, penalizing low performers,
losing volumes of patients, and increasing medical dis-
putes (1 = strongly agree, 2 = agree, 3 = neither agree nor
disagree, 4 = disagree, 5 = strongly disagree).
The last question of the instrument is about the promo-
tion strategy of public reporting, and it’s a multiple choices.
Items mainly based on the follow-up interview thematic
analysis outcomes conducted by Sherman, including
internal review before public reporting, third-party report-
ing, educating patients on data interpretation, presentingsimplified data to patients, more comprehensive risk strati-
fication and case-mix adjustment, and focusing on process
measures and not outcome measures. An additional file
shows the details of the instrument (see Additional file 1).
Statistical analysis
The mean Likert score with standard deviation (SD) and
frequency of positive responses were calculated for each
item at the institution- and individual-levels. One-sample
Kolmogorov-Smirnov test was used to determine if a
normal distribution of perceptions score was, the null hy-
pothesis is that “sample distribution is normal”, and if the
test is significant, the distribution is non-normal. For the
normal distribution perceptions score, the difference
would be compared using paired t-tests. Otherwise, non-
parametric test should be used. An analysis of variance
(ANOVA) test was used to analyze the differences of
Likert score among the three dimensions (i.e., necessity,
methodological rigor, and impact of public reporting). If
the ANOVA test showed a significant difference in means
between the three dimensions, then the Bonferroni
correction method will be employed to determine how
they differ. A p-value of < 0.05 was considered significant
for all comparisons except for the mean pair-wise analysis
with Bonferroni correction. For Bonferroni’s correction
method, the adjusted p-level was 0.0167, that is, the 0.05
was divided by 3 (the number of pair-wise comparisons in
this study was 3). All statistical analyses were performed
using SPSS17.0 (SPSS Inc., Chicago, IL).
Results
Characteristics of the participating GPs
A total of 154 questionnaires were distributed and all
of them were collected, the response rate was 100 %.
Table 1 shows the characteristics of these GPs. The
majority of GPs were males (61.44 %), and those be-
tween 31 and 60 years old accounted for over 80 %.
GPs in Q city possessed low-level education, that is,
only 18.18 % of the total GPs had completed a bache-
lor’s (or higher) degree. In terms of job title, the major-
ity of GPs (64.19 %) possess a primary title or lower.
GPs represented all units, including internal, surgery,
traditional Chinese medicine, gynecology and obstet-
rics, stomatology, psychiatry, and other units. The in-
come of most GPs (81.17 %) was less than 2500 RMB
yuan per month (USD 375, the exchange rate was US
$1 = RMB 6.67 in October 2016), but their working
time was considerably long, and over 70 % GPs worked
for more than 40 h a week.
Perceptions of GPs on the institution- and individual-level
medicine prescribing data reporting
In general, the positive response of GPs to the neces-
sity of institution-level reporting was higher than that
Table 1 Demographic characteristics of the respondents
Demographic characteristics Frequency Percent (%)
Gender Male 94 61.44
Female 59 38.56





Education Senior middle school
or lower
40 25.97




Title Not certified 8 5.41
Certified physician 34 22.97
Resident doctor 53 35.81
Attending doctor 44 29.73
Associate senior doctor 9 6.08
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however, no significant difference (p = 0.229) was ob-
served. For the methodological rigor dimension, the
positive response to institution-level reporting was
higher than that in individual-level reporting (i.e.,
68.18 % vs. 65.91 %), that is, GPs have more concerns
about individual- level reporting. However, the differ-
ence has no statistical significance (p = 0.387). Regard-
ing impact dimension, GPs have higher positive
response to institution-level reporting than that in
individual-level reporting (i.e., 83.12 % vs 81.49 %),
although no statistical difference (p = 0.881) was ob-
served. Table 2 shows the responses to each survey
item regarding the public reporting of institution- and
individual-level medicine prescribing data.Perceptions of GPs on the necessity, methodological
rigor, and impact of public reporting
The perceptions of GPs on the three dimensions (i.e., ne-
cessity, methodological rigor, and impact) have a signifi-
cant difference, regardless whether it is on the institution-
or individual-level data reporting (F = 19.18, p < 0.001 and
F = 12.54, p < 0.001, respectively). Further Bonferroni cor-
rection method test revealed that every two dimensions
have statistical significance except that the necessity
and impact dimension of individual- level data report-
ing (p = 0.138). Table 3 shows the specific results of
ANOVA and Bonferroni correction method test.
Strategies to facilitate the public reporting of medicine
prescribing data
Table 4 shows that the top three strategies that facili-
tate public reporting of medicine prescribing data were
focused on process measures and not outcome
measures (85.71 %), educating patients on data inter-
pretation (82.47 %), and more comprehensive risk
stratification and case-mix adjustment (76.62 %). GPs
believed that the third-party reporting and first internal
review before public reporting were effective strategies
to facilitate public reporting acceptance. A total of
74.03 and 68.83 % of GPs selected the two items, re-
spectively. Only 44.81 % of the surveyed GPs consid-
ered that presenting simplified data to patients was an
effective strategy to facilitate the public reporting.
Discussion
This study determined that the difference of perceptions
of GPs between public reporting of the institution- and
individual-level data lacked statistical significance. How-
ever, GPs expressed highest concerns regarding the
methodological rigor dimension of public reporting.
Thus, strategies should be considered to facilitate the
public reporting of medicine prescribing data, such as
disclosing process measures and educating patients on
data interpretation.
First, the lack of significant difference on the percep-
tions of GPs between the institution- and individual-
level data reporting should be explained. Public
reporting may result in negative impacts on market
share, contracting arrangements, or reputation of
health care providers [14, 15]. Generally speaking, for
self-preservation, the positive response of clinicians to
individual-level data reporting may be generally lower
than that in institution-level data reporting. However,
our results did not support this hypothesis. The
current transparency policy and medical environment
of China may explain this phenomenon. On the one
hand, provider incentives played an important role in
public reporting [16], but China’s transparency policy
lacks explicit incentives. Regardless whether GPs have
Table 2 Perceptions of GPs on the public reporting of institution- and individual-level medicine prescribing data
Survey Items Institution-level Individual-level T
T = (Mean1–Mean2)
p
Mean 1 (SD) Positive
response (%)
Mean 2 (SD) Positive response (%)
Necessity 3.94 (1.024) 82.14 3.81 (1.039) 76.95 0.13 0.229
Public reporting is necessary 3.89 (1.152) 78.57 3.69 (1.157) 71.75 0.19 0.096
Third-party reporting is necessary 3.98 (1.057) 81.49 3.92 (1.072) 79.22 0.06 0.566
Methodological rigor 3.35 (0.774) 68.18 3.34 (0.783) 65.91 0.01 0.387*
Patients cannot interpret or recognize data
complexity
3.10 (1.127) 49.03 2.99 (1.146) 46.43 0.11 0.428
Public reporting data is unreliable 3.72 (1.103) 73.53 3.73 (1.098) 73.70 −0.01 0.959
Lack of appropriately prescribed medicine metrics 3.64 (1.047) 69.48 3.66 (1.050) 70.45 −0.02 0.846
No adequate risk adjustment 2.86 (1.172) 41.50 2.86 (1.237) 41.88 −0.01 0.959
No adequate amount of prescriptions for statistical
comparison
3.23 (1.174) 56.49 3.23 (1.209) 55.84 −0.01 0.977
Lack of transparency of methodology 3.58 (1.083) 69.81 3.56 (1.078) 69.16 0.02 0.856
Impact 3.66 (0.622) 83.12 3.66 (0.636) 81.49 0 0.881*
Improved prescription quality 3.82 (1.032) 77.92 3.86 (1.032) 78.90 −0.04 0.716
GPs learn more knowledge on the rational
prescription of medicines
4.05 (1.008) 84.09 4.12 (0.952) 86.27 −0.07 0.636
Provide a sense of achievement to GPs 3.31 (1.100) 56.82 3.31 (1.093) 57.47 0.01 0.994
Refuse high-risk patients 3.5 (1.04) 68.63 3.5 (1.031) 68.51 0 0.995
Improve numbers and not quality 3.49 (1.074) 68.83 3.5 (1.080) 68.83 −0.01 0.92
Penalize low performing GPs 3.76 (1.010) 78.90 3.74 (1.015) 77.92 0.02 0.832
Loss of volume of patients 3.75 (0.873) 78.57 3.70 (0.951) 75.97 0.05 0.800
Increase medical disputes 3.59 (1.088) 70.13 3.57 (1.090) 69.16 0.02 0.854
Percentage of positive response = (1/2 number of GPs who obtained a score of 3 + all numbers of GPs who obtained a score of 4 + all numbers of GPs who
obtained score of 5)/ total number of GPs; * represents the p value calculated with paired t-tests; otherwise, calculated with nonparametric test; bold text
represents the results of dimension
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alty or reward. Therefore, GPs did not demonstrate
evident reluctance and concerns on the public reporting
of their own individual-level medicine prescribing data in
our study. On the other hand, education level and socio-
economic status have been demonstrated to affect theTable 3 Perceptions of GPs on the three dimensions of institution-
Dimension Institution-level
Score range Mean dimension
score (SD)
F
Necessity 1–5 3.94 (1.02) 19.18
Methodological rigor 1–5 3.35 (0.77)
Impact 1–5 3.66 (0.62)
aBonferroni correction Unadjusted
p
1 vs. 2 <0.001
1 vs. 3 0.011
2 vs. 3 0.003
dimension score = summed score of all items of the dimension / the number of item
“methodological rigor” dimension, 3 represents “impact” dimensionsearching habits of patients, and quality information was
used frequently by those with high education levels [17].
Patients in Q city with low levels of education may use
limited information to select the providers [18]. Therefore,
GPs’ perceptions of individual-level reporting were no
more negative than institution-level reporting becauseand individual-level medicine prescribing data reporting
Individual-level
p Score range Mean dimension
score (SD)
F p









<0.001 1 vs. 2 <0.001 <0.001
0.004 1 vs. 3 0.414 0.138
0.001 2 vs. 3 0.002 <0.001
s of the dimension; a1 represents “necessity” dimension, 2 represents
Table 4 Priority strategies to facilitate the public reporting of
medicine prescribing data
Survey Items N Frequency Percent (%)
Focus on process measures and not
outcome measures
154 132 85.71
Educate patients on data interpretation 154 127 82.47
More comprehensive risk stratification
and case-mix adjustment
154 118 76.62
Third-party reporting 154 114 74.03
Internal review before public reporting 154 106 68.83
Present simplified data to patients 154 69 44.81
Survey items are ranked based on frequency from highest to lowest
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Note that the results of Sherman’s study indicated
that most surgeons supported the public reporting of
quality metrics at the hospital level but opposed indi-
vidual reporting [6]. Therefore, the studies on the
perceptions of clinicians on the institution- and
individual-level data reporting showed mixed results
and required further research.
Second, compared with the necessity and impact of
public reporting, the methodological rigor was the di-
mension where GPs placed their utmost concern. This
result was consistent with those of previous studies. Barr
et al. conducted an interview to explore the view of physi-
cians on public reporting and determined that physicians
perceived that public reporting lacked methodological
rigor [19]. Rechel et al. mapped the current approaches of
public reporting in 11 high-income countries and learned
that the accuracy and reliability of performance data were
a main concern of public reporting [20]. Burns et al.
suggested that if public reporting was desirable, the
reporting data must be valid, and the main validity con-
cerns included sample size; model performance for risk
adjustment; and quality of the data [1]. Necessity and
impact have higher scores than methodological rigor,
thereby indicating that GPs viewed public reporting as
necessary and has significant influence on prescribing
practice. This result was similar to those of other studies.
Public reporting of provider quality information was
viewed as a necessary building block in the pursuit of
value-based health care [21]. Survey data from physi-
cians indicated that public reporting significantly influ-
ences performance improvement [22]. Recent data
from the Wisconsin Collaborative for Healthcare Qual-
ity showed that public reporting has an impact on
quality improvement [23, 24].
Finally, for the strategies to facilitate public reporting
acceptance, over 80 % of GPs involved deemed that pub-
lic reporting should focus on process measures and not
outcome measures, as well as educate patients on data
interpretation. The Agency for Healthcare Research andQuality (AHRO) showed that process measures have
been used for public reporting and have the following
advantages over the outcome measures: (1) process mea-
sures may be easier and less costly to measure, (2)
process measures can be advantageous when outcomes
of interest are rare or sample sizes are small, (3) and
well-specified process measures do not need case-mix or
risk adjustment [25]. The Process-Based Quality Im-
provement Manual stressed that process quality mea-
sures expand the domains of quality measurement and
were important to promote health care performance
[26]. Similar to emphasizing the importance of process
measures, several studies stressed the significance of
patient education during public reporting. Yang indi-
cated that consumer education was required to
maximize the impact of public reporting [27]. Stephanie
et al. suggested that education was required to help
assist patients interpret quality data, and an improved
public education on quality data was required to in-
crease the use of reporting data in the future [28].
The current study has a few limitations. First, as the
study was conducted in primary care institutions, the con-
clusions drawn from this research must be carefully gener-
alized to other types of healthcare institutions. Second,
this study was undertaken in just one city. Since socio-
economic and cultural may have an effect of GPs public
reporting perceptions, the GPs of our study may not be
representative of all GPs that with different economic and
cultural types. We may expand the sample size in the
future when other medical institutions public reporting
institution- and individual-level medicine use information.
Conclusion
This study determined no significant difference in the
GPs’ perceptions between institution- and individual-
level data reporting. Meanwhile, the utmost concern of
GPs lies on the methodological rigor of public reporting.
Extensive focus should be placed on the disclosure of
process measures and not outcome measures. Further-
more, patients should be educated on data interpretation
to improve the efficiency of public reporting.
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